日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations

药物人血清白蛋白制剂中不含 CXCR4 拮抗剂 EPI-X4

期刊:Journal of Translational Medicine
影响因子:6.1
doi:10.1186/s12967-021-02859-6
Andrea Gilg, Mirja Harms, Lia-Raluca Olari, Ann-Kathrin Urbanowitz, Halvard Bonig, Jan Münch
信号转导
Human
发表日期：2021
文献求助 收藏

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer

达拉非尼和曲美替尼治疗局部晚期或转移性BRAF V600突变型间变性甲状腺癌患者

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2017.73.6785
Subbiah, Vivek; Kreitman, Robert J; Wainberg, Zev A; Cho, Jae Yong; Schellens, Jan H M; Soria, Jean Charles; Wen, Patrick Y; Zielinski, Christoph; Cabanillas, Maria E; Urbanowitz, Gladys; Mookerjee, Bijoyesh; Wang, Dazhe; Rangwala, Fatima; Keam, Bhumsuk
肿瘤
肿瘤免疫
BRAF
甲状腺癌
免疫/内分泌
发表日期：2018
文献求助 收藏

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial

多维替尼与索拉非尼用于转移性肾细胞癌患者三线靶向治疗的比较：一项开放标签、随机3期试验

期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(14)70030-0
Motzer, Robert J; Porta, Camillo; Vogelzang, Nicholas J; Sternberg, Cora N; Szczylik, Cezary; Zolnierek, Jakub; Kollmannsberger, Christian; Rha, Sun Young; Bjarnason, Georg A; Melichar, Bohuslav; De Giorgi, Ugo; Grünwald, Viktor; Davis, Ian D; Lee, Jae-Lyun; Esteban, Emilio; Urbanowitz, Gladys; Cai, Can; Squires, Matthew; Marker, Mahtab; Shi, Michael M; Escudier, Bernard
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2014
文献求助 收藏

Decorin potentiates interferon-γ activity in a model of allergic inflammation

核心蛋白聚糖在过敏性炎症模型中增强干扰素-γ 活性

期刊:Journal of Biological Chemistry
影响因子:4
doi:10.1074/jbc.M112.419366
Carla Bocian, Ann-Kathrin Urbanowitz, Rick T Owens, Renato V Iozzo, Martin Götte, Daniela G Seidler
信号转导
发表日期：2013
文献求助 收藏